Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Not applicableWithdrawnNCT03238664
What this trial is testing

Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaTransitional Cell Carcinoma
University of Southern California
Testing effectiveness (Phase 2)Looking for participantsNCT06263153
What this trial is testing

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Who this might be right for
Bladder Urothelial CarcinomaMuscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more
Yuanquan Yang 24
Not applicableEnded earlyNCT02145390
What this trial is testing

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Bladder CancerBladder CarcinomaTransition Cell Cancer+1 more
University of Miami 1
Not applicableUnknownNCT04966130
What this trial is testing

Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 96
Not applicableLooking for participantsNCT05790850
What this trial is testing

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

Who this might be right for
Bladder CancerNon-muscle-invasive Bladder CancerMuscle-Invasive Bladder Carcinoma
University of Virginia 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04506554
What this trial is testing

Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fox Chase Cancer Center 81
Not applicableActive Not RecruitingNCT05295992
What this trial is testing

Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Varian, a Siemens Healthineers Company 110
Testing effectiveness (Phase 2)Looking for participantsNCT07579195
What this trial is testing

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Who this might be right for
Muscle Invasive Bladder CarcinomaStage III Bladder Cancer AJCC v8Stage IV Bladder Cancer AJCC v8
University of Washington 12
Early research (Phase 1)Looking for participantsNCT06173349
What this trial is testing

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

Who this might be right for
Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 12
Testing effectiveness (Phase 2)WithdrawnNCT02143804
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh GradeNon Muscle Invasive
CG Oncology, Inc.
Not applicableNot Yet RecruitingNCT06325423
What this trial is testing

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Assiut University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05776758
What this trial is testing

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

Who this might be right for
Muscle-Invasive Bladder CarcinomaChemotherapy EffectSurgery
Regina Elena Cancer Institute 236
Testing effectiveness (Phase 2)Study completedNCT03617913
What this trial is testing

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallStage II Bladder Cancer AJCC v8Stage II Renal Pelvis Cancer AJCC v8+9 more
Mayo Clinic 2
Testing effectiveness (Phase 2)Ended earlyNCT04871529
What this trial is testing

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Who this might be right for
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallInfiltrating Renal Pelvis and Ureter Urothelial CarcinomaStage II Bladder Cancer AJCC v8
SWOG Cancer Research Network 6
Not applicableLooking for participantsNCT07339761
What this trial is testing

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

Who this might be right for
Bladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)Muscle-Invasive Bladder Carcinoma
University of Aarhus 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06528483
What this trial is testing

Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerBladder Urothelial CarcinomaBladder Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05975307
What this trial is testing

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

Who this might be right for
Muscle-Invasive Bladder CarcinomaProgrammed Cell Death Protein 1 InhibitorRadiotherapy
Sun Yat-sen University 71
Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Testing effectiveness (Phase 2)Looking for participantsNCT05203913
What this trial is testing

Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 32
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Next Page